Not exact matches
So did mice treated with
breast milk that were genetically
engineered to have guts lacking receptors to EGF, as well as
normal mice treated with
breast milk depleted of EGF.
In addition to using
normal breast cancer cells in the experiments, the team also used cancer cells that had been genetically
engineered to lack either GSTO1 or RYR1.